Literature DB >> 25807477

Correlation Between Structural and Functional Retinal Changes in Parkinson Disease.

Manpreet Kaur1, Rohit Saxena, Digvijay Singh, Madhuri Behari, Pradeep Sharma, Vimla Menon.   

Abstract

BACKGROUND: To evaluate structural changes in the retina and correlate those with visual function measurements in patients with Parkinson disease (PD).
METHODS: A cross-sectional comparative study of 20 patients with PD and 20 age-matched healthy controls was conducted. Visual acuity, color vision, contrast sensitivity, visual fields, pattern visual-evoked response (VER), and multifocal electroretinogram were recorded to determine functional change, whereas structural changes were evaluated with retinal nerve fiber layer (RNFL) thickness, macular thickness, macular volume, and ganglion cell-inner plexiform layer complex (GCL-IPL) thickness using spectral domain ocular coherence tomography (SD-OCT).
RESULTS: PD patients ranged from Stage 1-3, with median Stage 2 (Hoehn and Yahr Classification) with mean Unified Parkinson Disease Rating Scale III score of 19 ± 10.42, and average disease duration of 5.8 ± 2.78 years. Visual acuity, color vision, and visual fields were unaffected but contrast sensitivity was significantly worse than controls (P < 0.001). Multifocal electroretinogram values in the central 2° field revealed decreased foveal electrical activity, with increased pattern VER amplitude and latency. Significant RNFL thinning was observed in the average RNFL (P = 0.033), superior (P = 0.018), and temporal (P = 0.036) quadrants. Significant ganglion cell layer loss was captured on SD-OCT with average, minimum GCL-IPL, and all 6 sectors showing thinning (P ≤ 0.003). The functional changes correlated significantly with structural changes, disease duration, and severity. There was no correlation between structural changes in the retina and disease duration or severity.
CONCLUSIONS: Subclinical visual dysfunction was observed in patients with PD with good structural-functional correlation. GCL-IPL thinning may be a more reliable parameter than RNFL thickness for structural alterations of the retina in patients with PD.

Entities:  

Mesh:

Year:  2015        PMID: 25807477     DOI: 10.1097/WNO.0000000000000240

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  16 in total

1.  Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease.

Authors:  A Ridder; M L T M Müller; V Kotagal; K A Frey; R L Albin; N I Bohnen
Journal:  Parkinsonism Relat Disord       Date:  2016-10-07       Impact factor: 4.891

2.  Visual dysfunction and its correlation with retinal changes in patients with Alzheimer's disease.

Authors:  V Polo; M J Rodrigo; E Garcia-Martin; S Otin; J M Larrosa; M I Fuertes; M P Bambo; L E Pablo; M Satue
Journal:  Eye (Lond)       Date:  2017-03-10       Impact factor: 3.775

3.  Graft versus self (GvS) against T-cell autoantigens is a mechanism of graft-host interaction.

Authors:  Nora Mirza; Manfred Zierhut; Andreas Korn; Antje Bornemann; Wichard Vogel; Barbara Schmid-Horch; Wolfgang A Bethge; Stefan Stevanović; Helmut R Salih; Lothar Kanz; Hans-Georg Rammensee; Sebastian P Haen
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-10       Impact factor: 11.205

4.  Combination of optical coherence tomography (OCT) and OCT angiography increases diagnostic efficacy of Parkinson's disease.

Authors:  Jing Zou; Kangcheng Liu; Fangling Li; Yi Xu; Lu Shen; Huizhuo Xu
Journal:  Quant Imaging Med Surg       Date:  2020-10

Review 5.  Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease.

Authors:  Jee-Young Lee; Antonio Martin-Bastida; Ane Murueta-Goyena; Iñigo Gabilondo; Nicolás Cuenca; Paola Piccini; Beomseok Jeon
Journal:  Nat Rev Neurol       Date:  2022-02-17       Impact factor: 44.711

6.  Reduced macular thickness and macular vessel density in early-treated adult patients with PKU.

Authors:  Csilla Serfozo; Andras Gellert Barta; Endre Horvath; Csaba Sumanszki; Bela Csakany; Miklos Resch; Zoltan Zsolt Nagy; Peter Reismann
Journal:  Mol Genet Metab Rep       Date:  2021-05-05

Review 7.  Past, present and future role of retinal imaging in neurodegenerative disease.

Authors:  Amir H Kashani; Samuel Asanad; Jane W Chan; Maxwell B Singer; Jiong Zhang; Mona Sharifi; Maziyar M Khansari; Farzan Abdolahi; Yonggang Shi; Alessandro Biffi; Helena Chui; John M Ringman
Journal:  Prog Retin Eye Res       Date:  2021-01-15       Impact factor: 19.704

8.  Visual dysfunction and its correlation with retinal changes in patients with Parkinson's disease: an observational cross-sectional study.

Authors:  V Polo; M Satue; M J Rodrigo; S Otin; R Alarcia; M P Bambo; M I Fuertes; J M Larrosa; L E Pablo; E Garcia-Martin
Journal:  BMJ Open       Date:  2016-05-06       Impact factor: 2.692

Review 9.  Patterns of Retinal Ganglion Cell Damage in Neurodegenerative Disorders: Parvocellular vs Magnocellular Degeneration in Optical Coherence Tomography Studies.

Authors:  Chiara La Morgia; Lidia Di Vito; Valerio Carelli; Michele Carbonelli
Journal:  Front Neurol       Date:  2017-12-22       Impact factor: 4.003

10.  Immune response in the eye following epileptic seizures.

Authors:  Matilda Ahl; Una Avdic; Cecilia Skoug; Idrish Ali; Deepti Chugh; Ulrica Englund Johansson; Christine T Ekdahl
Journal:  J Neuroinflammation       Date:  2016-06-27       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.